Cefotaxime sodium

Drug ingredientActive Shortage

CAS 64485-93-4

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 64485-93-4
1 Na⁺
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

3 FDA-registered drug labelers
ACS Dobfar S.p.A
Hikma Pharmaceuticals USA Inc.
SteriMax Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Cefotaxime
FDA Shortage Status
Active Shortage
Shortage History
  • Current shortage

    Cefotaxime Sodium Powder, for Solution

    Shortage listed since February 17, 2015

    Manufacturer reports: 1 unavailable, 1 available

See all current drug shortages

Chemical Identity

CAS64485-93-4
PubChem CID10695961
DTXSIDDTXSID4046991
FormulaC16H16N5NaO7S2
Mol. Weight477.5 g/mol
SMILESCC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]

Data Sources

Brief citations

Cefotaxime sodium (CAS 64485-93-4) https://chemicalindependence.com/chemical/64485-93-4/ PubChem: 10695961. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/10695961 FDA National Drug Code directory: CAS 64485-93-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 64485-93-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/